WuXi Biologics Boosts Complex Biologics Pipeline
WuXi Biologics partners with Sinorda on bispecific antibodies for autoimmune diseases and HanchorBio on fusion proteins for oncology and immunology.
Contract Development And Manufacturing Organizations (CDMO)
Siegfried to Acquire Small Molecules Drug Substance Capacity in the US
Siegfried signed binding agreements to acquire three drug substance sites in the US and Australia.
Agno Pharma Acquires US cGMP API Manufacturing Site
Agno Pharma acquired Actylis's Eugene, Oregon CDMO facility, formerly Cascade Chemistry, for small-molecule API development and manufacturing, thereby expanding its US footprint.
Adapting, Partnering, and Innovating: Insights from CPhI Frankfurt
How CDMOs are navigating uncertainty, forging partnerships, and embracing flexibility.
Resilient Industry Adapts to Challenges
SOCMA’s 2026 Contract Manufacturing Outlook shows a resilient, innovative specialty chemical sector, with SMBs driving agility amid tariffs, regulatory complexity, and global uncertainty.
WuXi AppTec Sells China Clinical Research Business to Sharpen Focus
WuXi AppTec has agreed to sell its China-based clinical research services business, including WuXi Clinical and WuXi MedKey, to Hillhouse Investment Management.
Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
Hovione Completes $100 Million Investment to Expand Operations at US Manufacturing Site
Hovione has completed a $100 million investment to double spray-drying capacity and expand its East Windsor, New Jersey site, positioning the facility to meet growing US demand.
SK Pharmteco Invests $6.1 Million in Peptide Manufacturing at California Facility
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Orion and Abzena Announce Exclusive Antibody Commercial License
Abzena, an end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s mAbs..
ESIM Chemicals Files for Bankruptcy
ESIM Chemicals filed for bankruptcy proceedings at the Linz Regional Court in mid-October. The Austrian specialty chemicals company is heavily indebted.
SOCMA Report Finds Specialty Chemical Manufacturers Strong, Adaptive, and Positioned for Growth
Three-year outlook highlights investment in automation, cybersecurity, and regulated manufacturing as key drivers of long-term competitiveness.
Aenova Expands Fill & Finish Capacities at its Latina site
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Fujifilm Biotechnologies Opens its Commercial-Scale Cell Culture US Manufacturing Site
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Symeres Appoints Gabriella Gentile as Chief Operating Officer
Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Symeres Acquires DGr Pharma
CRDMO Symeres has acquired DGr Pharma, expanding its capabilities with DGr Pharma’s regulatory and consultancy expertise to provide more comprehensive drug development services.
Bionova Scientific Opens New pDNA Facility in Texas
Bionova Scientific has opened a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
Sanner Appoints Stefan Verheyden CEO
Heino Lennartz will take over the role on an interim basis until Verheyden takes office in fall 2025.
Ofichem Acquires Meribel Pharma Solutions’ Uppsala Site
Ofichem, a European CDMO specialising in high-quality active pharmaceutical ingredients (APIs) and integrated drug development and manufacturing services, has acquired Meribel Pharma Solutions’ site in Uppsala, Sweden.
Abzena Appoints Geoffrey M. Glass as Chief Executive Officer
Abzena, an end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, recently announced that Geoffrey M. Glass has been appointed Chief Executive Officer, effective immediately.
Sanner Opens its First US Production Facility in North Carolina
Sanner, a provider of high-quality healthcare packaging and drug delivery solutions, officially opened its first US-based production facility in Greensboro, North Carolina.
Marianne Späne to Leave Siegfried Management
The pharmaceutical service provider Siegfried has announced changes to its management team. Marianne Späne, who has been with the Swiss CDMO since 2004 and has held the position of Chief Business Officer since the beginning of 2020, is moving to the Board of Directors of the subsidiary Dinamiqs.
Flamma Opens New cGMP Plant in China
The Flamma Group, a Contract Development and Manufacturing Organization (CDMO), recently celebrated the grand opening of a new cGMP plant in Dalian, China.
GenSight Biologics to Partner with Catalent on Gene Therapy Candidate
GenSight Biologics recently announced the successful transfer of the upstream phase of the manufacturing process for LUMEVOQ, the Company’s gene therapy candidate product to CDMO Catalent.
Aenova Expands its Refrigerated Logistics for Biologics
Aenova is investing in a new cold storage infrastructure at its sterile site in Latina (Italy), offering an end-to-end supply chain solution for biologics and other pharmaceutical products.
Mabion Launches €500,000 Oncology Services Contest
Mabion, a biotech-focused CDMO offering end-to-end services, has announced the launch of a €500,000 oncology services contest at BIO International Convention 2025.
Resilience Will Close 6 of its 10 Plants
Resilience recently shared that capacity expansions have exceeded current industry demand. As a result, Resilience has begun consolidating its operations and streamlining its business strategy.
Sterling Pharma Solutions and Kivu Bioscience Enter Manufacturing Pact
Sterling Pharma Solutions to produce an antibody-drug conjugate (ADC) candidate for Kivu Bioscience.
Fujifilm Rebrands Life Sciences Companies
Fujifilm Irvine Scientific becomes Fujifilm Biosciences, and Fujifilm Diosynth Biotechnologies will be known as Fujifilm Biotechnologies.
Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites
Curia, a CDMO, recently shared expansion plans for facilities in Glasgow, UK, and Albuquerque, NM, US.
Siegfried Expands Production Capacity in El Masnou
Siegfried announced a further expansion of its ophthalmic drug manufacturing site in El Masnou near Barcelona, Spain.
Motivation, Innovation, and the Power of Collaboration
Leading the Way in Pharmaceutical Manufacturing by Fostering an Agile Mindset and an Inclusive Culture.
Hovione and Firstgene Announce Strategic Collaboration
Exclusive licensing and R&D collaboration between Hovione and Firstgene.
Aenova Launches Program to Accelerate Pharmaceutical Development
Aenova announces the launch of its Aenovation program. This initiative aims to accelerate the early development of pharmaceutical formulations.
